An analysis of Pharmaceutical Benefits Scheme (PBS) data in 2019 suggests that a reliance on PPIs for management of reflux symptoms remains.

After medicines were delivered to the wrong person, the coroner has recommended a new safety measure to curb inadvertent errors.

In a world-first decision, the TGA has created a Schedule 8 listing for psilocybin and MDMA. But how will this decision impact pharmacists?

From emergency contraception to migraines, advance supply can be appropriate. Here’s how to decide when it is – and isn’t.

The Therapeutic Goods Administration issued an alert over a commonly used of broad-spectrum class of antibiotics.

The TGA is reviewing andrographis after hundreds of serious adverse events raise safety concerns.